The APOBEC3 (A3) deaminases are retrovirus restriction factors that were proposed as inhibitory components of HIV-1 gene therapy vectors. However, A3 mutational activity may induce undesired genomic damage and enable HIV-1 to evade drugs and immune responses. Here, we show that A3A protein from Colobus guereza (colA3A) can restrict HIV-1 replication in producer cells in a deaminaseindependent manner without inducing DNA damage. Neither HIV-1 reverse transcription nor integration were significantly affected by colA3A, but capsid protein synthesis was inhibited. The determinants for colA3A restriction mapped to the N-terminal region. These properties extend to A3A from mandrills and De Brazza's monkeys. Surprisingly, truncated colA3A proteins expressing only the N-terminal 100 amino acids effectively exclude critical catalytic regions but retained potent cellular restriction activity. These highlight a unique mechanism of cellular HIV-1 restriction by several Old World monkey A3A proteins that may be exploited for functional HIV-1 cure strategies.
Introduction
Humans express several innate host factors that restrict the replication of lentiviruses such as human immunodeficiency virus type 1(HIV-1). These innate restriction factors include the apolipoprotein B mRNA-editing enzyme catalytic peptide 3 (APOBEC3; A3) proteins, bone marrow stromal antigen 2 (BST-2, also known as CD317, HM1.24 or tetherin), and tripartite motif (TRIM) proteins (Neil et al., 2008; Sheehy et al., 2002; Stremlau et al., 2004; Van Damme et al., 2008) . These restriction factors have been the focus of intense study during the past decade due to their translational potential as novel drug targets and as antiviral components of gene therapy configurations for functional HIV-1 cure strategies (Ao et al., 2011; Bushman, 2002; Voit et al., 2013) .
The A3 family of proteins includes seven members (A3A, A3B, A3C, A3D, A3F, A3G, and A3H) whose genes are tandemly arranged on human chromosome 22 and rhesus macaque chromosome 10 (Jarmuz et al., 2002; Schmitt et al., 2011) . The APOBEC3 proteins are cytidine deaminases that also include activation-induced cytidine deaminase (AID), APOBEC1, APOBEC2, and APOBEC4. All A3 proteins have a canonical zinc-coordinating deaminase domain (H-x-E-x 23-28 -PC-x 2-4 -C) that converts cytidine to uracil (C-to-U) in DNA targets (MacGinnitie et al., 1995) . The seven A3 proteins can be further divided into those with a single deaminase domain (A3A, A3C, and A3H) and with two deaminase domains (A3B, A3D, A3G, A3F) (Desimmie et al., 2013; Kitamura et al., 2011; Refsland and Harris, 2013) . The anti-HIV-1 activity of the human A3G (hA3G) was initially discovered during the characterization of wild type HIV-1 and HIV-1Δvif viruses produced from permissive (non-A3G expressing) and non-permissive (A3G expressing) cells (Sheehy et al., 2002) . A3G has been shown to restrict HIV-1Δvif by both deaminase-dependent and independent mechanisms. Restriction requires its incorporation into the viral nucleocapsid during virion egress from producer cells. The Vif protein counteracts A3G incorporation by acting as an adapter that interacts with both A3G and members of the Cullin 5 E3 ligase complex (Mehle et al., 2004 (Mehle et al., , 2006 Xiao et al., 2006) . This results in the ubiquitination both Vif and the A3G and subsequent degradation by the proteasome, thus limiting the amount of A3G that could be incorporated into virions (Conticello et al., 2003; Iwatani et al., 2007; Liu et al., 2004; Marin et al., 2003; Mehle et al., 2004; Sheehy et al., 2002 Sheehy et al., , 2003 Yu et al., 2003) . The mechanism for how hA3G inhibits HIV-1Δvif replication is controversial, with different groups preferring either a deaminase-dependent or deaminase-independent mechanism (Santiago and Greene, 2007) . When A3G containing viruses infect a target cell, the incorporated A3G causes cytidine deamination of minus strand viral DNA during reverse transcription (Chelico et al., 2006; Yu et al., 2004) . The end result of the action of this cytidine deaminase is G-to-A mutations in the sense strand of the viral DNA incorporated into the host chromosome. Deaminase-independent mechanisms of restriction involve inhibition of reverse transcription by preventing: (a) tRNA annealing to the viral RNA; (b) DNA elongation; and (c) strand transfer (Guo et al., 2006 Iwatani et al., 2007; Li et al., 2007; Yang et al., 2007) . Another report showed that A3G and A3F can interact with integrase and prevent integration (Luo et al., 2007) .
Previous studies have shown that hA3A does not restrict the replication of HIV-1Δvif in CD4 þ T cells but restricts HIV-1Δvif in macrophages (Berger et al., 2011; Bishop et al., 2004; Koning et al., 2011; Thielen et al., 2010) . The inability of hA3A to restrict HIV-1Δvif has been linked to its poor incorporation into the nucleocapsid complex during maturation. Targeting hA3A to the nucleoprotein complex by either fusion to the N-terminal domain of A3G or fusion to Vpr results in enhanced incorporation and restriction activity (Aguiar et al., 2008; Goila-Gaur et al., 2007) . Human A3A has been shown to inhibit retrotransposition, to induce DNA damage responses, and inhibit the replication of adeno-associated viruses and autonomously replicating parvoviruses (Bogerd et al., 2006; Bulliard et al., 2011; Chen et al., 2006; Landry et al., 2011; Muckenfuss et al., 2006; Narvaiza et al., 2009 ). Finally, hA3A can restrict HTLV-I and can cause G-to-A hypermutation of human papillomavirus, herpes simplex 1 and Epstein Barr virus genomes (Ooms et al., 2012; Suspène et al., 2011b; Vartanian et al., 2008) .
Until recently, all APOBEC3 proteins shown to restrict HIV-1Δvif replication do so in the target cell, not the producer cell. In an effort to understand APOBEC3-mediated lentivirus restriction from an evolutionary perspective, we examined the virus restriction activity of several Old World monkey A3A proteins and showed that the A3A protein from the black and white colobus monkey (mantled guereza; Colobus guereza; colA3A) potently inhibited not only HIV-1Δvif replication but also wild-type HIV-1 in producer cells (Schmitt et al., 2013) . In this report, we extend these findings by showing that the N-terminal domain of colA3A is critical for cellular HIV-1 restriction, that the A3A proteins from other OWM can also restrict the replication of wild type HIV-1 and that colA3A affects HIV-1 replication at a post-integration step. The results could have important implications in designing genetherapy approaches using on the unique HIV-1 restriction properties of colA3A, mndA3A or debA3A.
Results
Cells expressing HA-colA3A inhibit HIV-1 production TZM-bl cells were transfected with a vector expressing HA-colA3A and selected for G-418 resistance for 2 weeks. The resulting G-418 resistant cells were analyzed for the expression of HA-colA3A by immunoprecipitation using an antibody against the HA-tag. The immunoprecipitation analysis revealed that the TZM-bl cells transfected with the vector expressing HA-colA3A expressed HA-colA3A while the parental TZM-bl cell line was negative for HA-colA3A expression ( Fig. 1A) . We used these HA-colA3A expressing cells to determine if they would restrict the replication of HIV-1. TZM-bl cells expressing HA-colA3A were inoculated with HIV-1 at an MOI of 1.0 and at 48 h post-inoculation, the culture supernatants were assessed for Gag p24 release (Fig. 1B) . The results indicate that HIV-1 production was significantly inhibited in TZM-bl cells expressing HA-colA3A, analogous to our previous co-transfection studies (Schmitt et al., 2013) .
ColA3A does not affect HIV-1 reverse transcription
We determined if colA3A inhibited reverse transcription of HIV-1. For these experiments, 293 cells were transfected with either the empty pcDNA3.1( þ ) vector or one expressing HA-colA3A. At 24 h post-transfection, cultures were inoculated with VSV-G pseudotyped envelope glycoprotein defective HIV-1 (HIV-1ΔE-/VSV-G) and incubated for 0 or 24 h. Total DNA was isolated, RNase A-treated and used in PCR reactions to detect late (U5-gag) reverse transcription products. While the results indicate that the nucleoside reverse transcriptase inhibitor AZT inhibited U5-gag products, the levels of late reverse transcription products were not statistically different between cells transfected with the empty vector or one expressing HA-colA3A (Fig. 2) . These findings indicate that colA3A does not inhibit HIV-1 replication at the step of reverse transcription.
ColA3A does not affect HIV-1 integration
One of the consequences of inefficient integration is an increase in the number of 2-LTR circles (Butler et al., 2001) . 293 cells were transfected with a vector expressing colA3A for 24 h followed by inoculation of cultures HIV-1ΔE/VSV-G. The cells were incubated for an additional 48 h and real time DNA PCR used to quantify the levels of 2-LTR circles (Butler et al., 2001) . Controls for 2-LTR circle formation included 293 cells inoculated with HIV-1ΔE/VSV-G in We also used real time DNA PCR to quantify the levels of integration events using established procedures for detecting Alugag sequences (Butler et al., 2001) . The results of real time DNA PCR indicated a 100-fold decrease in the levels of Alu-gag sequences detected in DNA samples from 293 cultures transfected with the empty vector pcDNA3.1( þ) followed by inoculation with HIV-1ΔE/VSV-G in the presence of 20 nM raltegravir versus 293 cultures transfected with pcDNA3.1( þ ) and inoculated with HIV-1ΔE/VSV-G in the absence of raltegravir (Fig. 3B ). The levels of Alu-gag sequences detected in the 293 cells transfected with a plasmid expressing colA3A and inoculated with HIV-1ΔE/VSV-G were not statistically different from cultures transfected with pcDNA3.1( þ) and inoculated with HIV-1ΔE/VSV-G. The results of the 2-LTR circles and Alu-gag assays indicate that colA3A did not significantly affect integration.
The N-terminal region of the colA3A contains the critical determinants for restricting HIV-1 production
We previously showed that hA3A did not restrict HIV-1Δvif while colA3A restricted both HIV-1 and HIV-1Δvif (Schmitt et al., 2011 (Schmitt et al., , 2013 . Chimeric colobus/human A3A proteins were constructed to define the determinants of colA3A restriction (Fig. 4 ). All human/colobus chimeric proteins were expressed well in 293 cells (Fig. 5A ). The first two chimeric colobus/human A3A chimeras tested was col 1-100 hA3A, in which the first 100 amino acids of colA3A were fused to the C-terminal region of hA3A and h 1-100 colA3A, in which with the first 100 amino acids of hA3A fused to the C-terminal region of colA3A. The results of the restriction assays indicated that col 1-100 hA3A but not h 1-100 colA3A restricted HIV-1 infectious virus production as measured using the TZM.bl assay ( Fig. 5B and C). We also examined chimeric proteins with the N-terminal 75, and 50 amino acids of colA3A fused to hA3A (col 1-75 hA3A, col 1-50 hA3A). Restriction assays showed that col 1-75 hA3A, col 1-50 hA3A and col 1-33 hA3A restricted HIV-1 at approximately 5%, 10%, and 15% of the empty vector control, respectively. We also examined the levels of p24 release and obtained similar results ( Fig. 5C ). However, if we normalized infectious titer to p24 levels we observed no effect on HIV-1 virion infectivity (data not shown). These results indicate that the colA3A N-terminal domain harbor the critical determinants for HIV-1 restriction.
Copy numbers/μg 300,000 240,000 180,000 120,000 60,000 0 U5-gag At 24 h post-inoculation, the cells were washed three times, total DNA extracted, and the levels of U5-gag transcripts quantified using real time DNA PCR as described in the text. The values obtained are presented as copies/μg. The experiments were performed at least four times and statistical differences with the untagged rhA3A control were evaluated using a two-tailed Student's t-test, with p o0.05 (Δ) considered significant. Shown is the mean percentage virion infectivity with the empty plasmid control normalized to 100%. 
ColA3A inhibits HIV-1 virus protein synthesis in producer cells
Since colA3A does not inhibit HIV-1 reverse transcription and integration, but had a reproducible inhibitory impact on virion release, we next evaluated the levels of intracellular Gag p24 levels. Infected cells were lysed and p24 levels quantified. As shown in Fig. 5D , the levels of p24 in the cell lysates were dramatically reduced in colA3A-transfected, but not hA3A-transfected, producer cells. We further mapped the inhibition of cellular p24 synthesis of colA3A to the N-terminal domain (Fig. 5D ). The levels of p24 in the cell lysates paralleled the levels of p24 release (compare Fig. 5C and D). Thus, colA3A inhibits virus protein production in producer cells.
Other Old World monkey A3A proteins restrict HIV-1 replication by a mechanism similar to colA3A
As colA3A 1-100 hA3A but not h 1-100 col A3A had opposite effects on restricting HIV-1, we examined the N-terminal sequences of the several OWM to determine if the A3A sequences from other OWM were similar to colA3A ( Fig. 6 ). Our analysis indicates that the A3A proteins from Mandrillus sphinx (mndA3A) and Cercopithecus neglectus (debA3A) had an AC-loop1 region that was similar to colA3A. We generated constructs in pcDNA3.1( þ) vector as we previously described for HA-rhA3A, and HA-colA3A (Schmitt et al., 2013) . Both mndA3A and debA3A were expressed well in 293 cells ( Fig. 7A ). 293 cells were transfected with vectors expressing either hA3A, rhA3A, colA3A, debA3A, or mndA3A and plasmids with the genomes of HIV-1. The culture supernatants were harvested and cell lysates prepared at 48 h and assayed for p24 content and infectivity using TZM-bl cells. The experiment was repeated at least four times. As shown in Fig. 7B , colA3A, debA3A and mndA3A restricted HIV-1 while hA3A and rhA3A did not restrict HIV-1 replication. Similar to colA3A, the levels of p24 in the culture supernatants and cell lysates prepared from producer cells were significantly reduced compared to empty vector controls or cells transfected with vectors expressing hA3A ( Fig. 7C and D).
To determine if restriction by these select OWM A3A proteins is specific to lentiviruses, we tested if A3A can inhibit a gammaretrovirus, Friend Murine Leukemia virus (F-MuLV). We specifically evaluated the mndA3A, as it was the consistently most potently restricted virus HIV-1. An F-MuLV infectious molecular clone was co-transfected with the empty vector, or vectors expressing hA3A, rhA3A, mndA3A, or hA3G. The A3A proteins were expressed well in transfected cells (Fig. 7E ). Consistent with other previous studies (Santiago et al., 2008; Takeda et al., 2008) , hA3G potently restricted F-MuLV replication (Fig. 7F ). Moreover, as expected from a recent study (Stavrou et al., 2014) , hA3A partially inhibited F-MuLV replication. Interestingly, rhA3A and mndA3A did not restrict Fr-MuLV replication (Fig. 7F ). These findings demonstrate not all retroviruses are susceptible to mndA3A restriction.
Truncated colA3A, mndA3A and debA3A proteins can restrict HIV-1
As the above results indicated that the first 100 amino acids of colA3A contained the determinants of HIV-1 restriction, we determined if truncated colA3A, mndA3A and debA3A proteins could also restrict HIV-1 replication. Truncated versions of colA3A were constructed that expressed the N-terminal 100 amino acids (colA3A 1-100 , mndA3A 1-100 , debA3A 1-100 ). We next examined the intracellular localization of HA-colA3A and HA-colA3A 1-100 in transfected 293 cells using immunofluorescence and confocal microscopy to determine if the truncated A3A was localized in different compartments than the unmodified A3A protein. 293 cells were transfected with the empty vector or vectors expressing either mndA3A or mndA3A 1-100 . At 48 h cells were examined for the intracellular localization of the A3A proteins using an anti-HA antibody. The results indicate that similar to HA-colA3A, HA-colA3A 1-100 was also localized in both the cytoplasmic and nuclear compartments of the cell (Fig. 8A-F) . We next examined the restriction activity of these A3A proteins. 293 cells were transfected with plasmids with the HIV-1 genome and 48 h later the culture medium was harvested. The levels of p24 Gag were measured and levels of infectious virus determined using TZM-bl assays. Our results show that the truncated A3A proteins were just as effective as the full length colA3A at restricting infectious HIV-1production ( Fig. 9A and B) . The truncated colA3A, debA3A, and mndA3A also inhibited HIV-1 p24 synthesis in producer cells and release into the culture supernatants, similar to the full length counterparts ( Fig. 9C and D) . As negative controls, rhA3A did not restrict HIV-1 in these experiments.
A chimeric hA3A containing the AC Loop1 region of mndA3A restricts HIV-1
Previously we reported that substitution of the hA3A AC loop 1 region with rhA3A restricted the replication of HIV-1Δvif. We were very interested in the mndA3A as it restricted HIV-1 to a higher level than either colA3A and debA3A. We constructed and expressed a chimeric hA3A/mndA3A in which the AC Loop1 region of hA3A ( 27 GI-GRHK 32 ) was exchanged for AC Loop 1 region of mndA3A ( 27 KLWVSGQRE 35 ) (Fig. 6 ). This chimera, designated as mnd [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] hA3A was used in restriction assays along with hA3A, mndA3A, colA3A and an empty vector control. The results of the restriction assays revealed that the mnd 25-34 hA3A was nearly as effective at mndA3A at restricting HIV-1 while hA3A did not restrict HIV-1 ( Fig. 10A-C) . These results indicate that the AC Loop1 region of mndA3A was critical to its restriction properties.
Induction of a DNA damage response by full length colA3A but not truncated colA3A It was previously shown that hA3A could induce a DNA damage response resulting in the phosphorylation of H2AX to γH2AX (Landry et al., 2011) . It remains unknown whether this property is conserved in colA3A. We therefore determined if colA3A induced a DNA damage response in 293 cells. Controls for induction of γH2AX were cells incubated with 20 μM etoposide (Tanaka et al., 2007) . Cells were transfected with the empty vector pcDNA3.1( þ) or vectors expressing HA-hA3A or HA-colA3A for 36 h. At this point the cells were either left untreated or treated with 20 μM etoposide for 12 h. At 48 h the cells were lysed and examined for γH2AX expression by immunoblots using a γH2AX specific antibody. Background levels of γH2AX expression were observed 293 cells or 293 cells transfected with the empty vector while cultures treated with 20 μM etoposide clearly induced the expression of γH2AX and its monoubiquitinated variant (Fig. 11 ). Transfection of 293 cells with vectors expressing hA3A showed low levels of γH2AX expression and its monoubiquitinated variant compared to treatment with 20 μM etoposide while cells transfected with the vector expressing colA3A showed just above background levels of γH2AX expression (Fig. 11) . These data indicate that hA3A and perhaps colA3A induced γH2AX (albeit a small response compared to etoposide) when exogenously expressed from strong promoters.
Since HA-colA3A 1-100 was also effective at restricting HIV-1 and that the determinants required for A3A to induce H2AX are largely unknown, we determined if this truncated proteins would induce γH2AX. 293 cells were transfected with the empty control vector or vectors expressing HA-hA3A, HA-colA3A, and HA-colA3A 1-100 for 48 h. Cells were stained for the presence of γH2AX by immunofluorescence using a γH2AX-specific antibody. Expression of γH2AX was not detected in 293 transfected with the empty vector but low levels of γH2AX could be detected in cells transfected with the vector expressing hA3A when compared with cells treated with 20 μM etoposide (Fig. 11 ). However, 293 cells transfected with vectors expressing HA-colA3A 1-100 for 48 h did not induce γH2AX expression. Taken together, these data indicate that HA-colA3A 1-100 did not induce a DNA damage response when exogenously expressed.
Discussion
Deciphering the mechanism of colA3A restriction could be instrumental in designing novel antiviral strategies against HIV-1. We show here that TZM-bl cells expressing colA3A (TZM-bl-colA3A) inoculated with either HIV-1 or HIV-1Δvif viruses recapitulated the observed virus restriction using plasmids, thus ruling out that the observed colA3A restriction was an artifact of transfection process. Our studies also showed that colA3A does not target the reverse transcription or integration steps of the virus replication cycle and that cytidine deamination is not involved. These data provide additional support that colA3A restricts virus replication by a novel deaminase-independent mechanism not previously described for any APOBEC3 protein.
In a previous study, the binding efficiency of hA3A to a 40 nucleotide ssRNA was reported to be approximately 3-fold higher than for the corresponding 40 nt ssDNA (Byeon et al., 2013) . More recently, it was shown that hA3A binds single stranded RNA (ssRNA) but no deamination of ssRNA occurs (Mitra et al., 2014) . Thus, it is possible that colA3A with its different AC-loop-1 region may interact more strongly with ssRNA than ssDNA and may inhibit virus replication by interfering in transcription and/or translation. We previously used a chimeric protein approach to show that substitution of AC loop1 of hA3A with that of rhA3A restored the ability to hA3A to restrict HIV-1Δvif (Schmitt et al., 2013) . We hypothesized that the three amino acid insertion in AC loop 1 of rhA3A could result in a AC-Loop1 with a greater molecular surface compared to hA3A. Due to its predicted solvent-accessibility, this additional molecular surface may be an important region for protein-protein interactions (Schmitt et al., 2013) . Using a similar approach we found that determinants within the N-terminal domain (i.e. the first 100 amino acids) which includes the AC Loop-1 region of colA3A are likely involved in the restriction of HIV-1 as chimeric proteins col 1-100 hA3A restricted at levels similar to full length A3A while col 1-75 hA3A, col 1-50 hA3A, and col 1-33 hA3A showed a gradual reduction in the Fig. 7 . The A3A proteins from other Old World monkeys also restrict HIV-1 by a similar mechanism. Panel A. Expression of the wild type and chimeric A3 proteins. 293 cultures were transfected with the empty pcDNA3.1(þ ) vector or those expressing hA3A, rhA3A colA3A, mndA3A, or debA3A. At 48 h, cells were starved and radiolabeled with 35 S-methionine/ cysteine for 6 h. The medium was removed, cell lysates prepared in 1XRIPA buffer and HA-tagged proteins immunoprecipitated with a rabbit antibody against the HA-tag and protein A Sepharose. The proteins were resolved using SDS-PAGE and visualized by standard radiographic techniques. The lanes correspond to the vector used to transfect the 293 cells. Panels B-D. 293 cells were transfected with pcDNA3.1(þ)empty vector or vectors expressing either hA3A, colA3A, rhA3A, mndA3A, or debA3A and the vector with the HIV-1 genome. At 48 h, the culture supernatants were collected and assayed for infectious virus using TZM-bl as an indicator cell line or p24 levels in the culture supernatant and in cell lysates. Panel B. The level of infectious virus in the culture supernatants from transfected cells using TZM.bl assays. Panel C. Levels of p24 antigen in the culture supernatants from transfected cells using commercially available p24 antigen capture kits. Panel D. Levels of p24 antigen in the cell lysates from transfected cells using commercially available p24 antigen capture kits. The experiments in panels B-D were performed at least four times and statistical differences with the pcDNA3.1(þ)/HIV-1 control evaluated using a two-tailed Student's t-test, with po0.05 (Δ) considered significant. Panels E and F. F-MuLV is not sensitive to mndA3A. The pLRB302 F-MuLV infectious molecular clone were co-transfected with A3A constructs into 293T cells. A3A expression were evaluated by western blot and infectious titers were quantified using a focal infectivity assay in Mus dunni cells. The experiments in Panels B-F were performed at least twice and statistical differences with the pcDNA3.1(þ )/HIV-1 control evaluated using a two-tailed Student's t-test, with po0.05 (Δ) considered significant.
level of restriction although they were still at statistically significant levels. Analysis of the AC-Loop-1 regions from hA3A and colA3A revealed significant variability in N-terminal domain sequences. We analyzed the A3A sequences of other OWM with AC Loop1 ( 25 KPWVSGQRE 33 ) sequences similar to colA3A. We found that the A3A proteins from both C. neglectus (debA3A; 25 KPWVSGQRE 33 ) and M. sphinx (mndA3A; 25 KLWVSGQHE 33 ) were identical or nearly identical to colA3A in this region. Similar to colA3A, we observed that debA3A and mndA3A restricted HIV-1 with mndA3A being slightly more restrictive than colA3A and debA3A. The restriction of HIV-1 by these A3A proteins appears to be specific since mndA3A did not restrict Friend MuLV, gammaretrovirus. The Old World monkeys (Family Cercopithecidae) are composed of two subfamilies (Cercopithecinae and Colobinae). The Cercopithecinae are further classified into two tribes, the Cercopithecini, and the Papionini. The Colobiniae are generally classified into the African and Asian colobines. Our findings indicate that restriction of wild type HIV-1 by A3A is represented by species in two tribes of the Cercopithecinae (Cercopithecini, debA3A; and Papionini, mndA3A) and by the African group of the Colobinae. These results also reinforce our previous findings that the sequence of the AC Loop1 region is critical for restriction of wild type HIV-1 by OWM A3A proteins. Notably, while these three monkey species express an A3A that restricts HIV-1, all three monkeys are known to harbor endemic SIV infections (SIV col , SIV mnd , and SIV deb ) (Courgnaud et al., 2001; Souquiere et al., 2001; Bibollet-Ruche et al., 2004) . It will be of interest to determine if the Vif protein from these SIV strains counteract the corresponding A3A proteins to allow for productive SIV replication. Moreover, it will be of interest to determine if other OWM species also express A3A proteins that restrict HIV-1 in producer cells and if the hA3A protein can potently inhibit HIV-1 with a few amino acid substitutions mimicking the colA3A in the AC-loop 1 region.
A major difference between the A3A proteins and those of the Old World monkeys is a 3 amino acid deletion from the AC Loop1 region in the hominids. Previously, we showed that deletion of these amino acids from the rhA3A abolished its ability to restrict SHIVΔvif (Schmitt et al., 2011) . Subsequently, we showed that substitution of the hA3A AC Loop1 region with the same region of rhA3A endowed this chimeric hA3A with the ability to restrict HIV-1Δvif (Schmitt et al., 2013) . As our chimeric human/colobus protein data indicated that the determinants of restriction were associated with the N-terminal domain, we determined if the AC loop1 region was once again critical to this restriction. As the mndA3A consistently restricted HIV-1 to a higher level of the three Old World monkey A3A proteins tested, we constructed an hA3A contained the mndA3A AC loop 1 region. Our results indicated that the level of virus restriction by mnd 25-34 hA3A was similar to mndA3A indicating that this region was critical for restriction of HIV-1. Recently, it was shown that this region in hA3A was important in controlling substrate specificty (Logue et al., 2014) . These investigators showed that a chimeric hA3A/A3G protein with the AC Loop 1 region (referred to as recognition loop 1or RL1) of hA3G was more flexible with respect to the nucleotide 5 0 to the deaminated C, deaminating AC, CC, and GC with increased frequency. Unfortunately these investigators did not examine the virus restriction of this chimeric hA3A/A3G protein.
Nevertheless, these results further highlight the importance of this region in the biological function of this single deaminase domain protein.
As our data showed that the N-terminal region of colA3A had the determinants for HIV-1 restriction and that mndA3A and debA3A also restricted HIV-1, we determined if truncation of these A3A proteins retained the ability to restrict HIV-1. Our data clearly indicated that all three truncated A3A proteins (colA3A 1-100 , mndA3A 1-100 , and debA3A 1-100 ) restricted HIV-1. Similar to the full length A3A proteins, the restriction involved reduced Gag expression in the producer cells. These results indicate that the HA-colA3A 1-100 HA-colA3A pcDNA3.1(+) Anti-HA DAPI Fig. 8 . HA-colA3A 1-100 is expressed in both the cytoplasm and nucleus. 293 cells were transfected with either the empty vector, HA-colA3A or HA-colA3A 1-100 . At 48 h, the cells were washed, fixed and stained using an antibody against the HA-tag conjugated with Alexa488 and counterstained with DAPI to visualized the nuclei. The stained cells were visualized using a Leica TCS SPE laser scanning confocal microscope using filters to visualize the DAPI (Panels A-C) visualize the Alexa488 (Panels D-F). Shown are micrographs of cells transfected with empty pcDNA3.1( þ) vector (Panels A and D), HA-colA3A (Panels B and E), and HA-colA3A 1-100 (Panels C and F). canonical cytidine deamination domain was not essential for restriction and represents the first demonstration that a single deaminase A3 protein could be significantly truncated (i.e., $ 50%) without loss of restriction activity. These results further support the idea that some A3 proteins evolved the capacity to inhibit lentiviruses in a deaminase-independent manner. Fig. 9 . Truncated colA3A, mndA3A, and debA3A proteins restrict wild type HIV-1. Panel A. Expression of the wild type and chimeric A3 proteins. 293 cultures were transfected with the empty pcDNA3.1(þ ) vector or vectors expressing colA3A, mndA3A, debA3A, colA3A 1-100 , mndA3A 1-100 , or debA3A 1-100 . At 48 h, cells were starved and radiolabeled with 35 S-methionine/cysteine for 6 h. The medium was removed, cell lysates prepared in 1 Â RIPA buffer and HA-tagged proteins immunoprecipitated with an antibody against the HA-tag and protein A Sepharose. The proteins were resolved using SDS-PAGE and visualized by standard radiographic techniques. The lanes correspond to the vector used to transfect 293 cells. Panels B-D. 293 cells were transfected with either the empty vector or plasmids expressing hA3A, colA3A, colA3A 1-100 , mndA3A 1-Human A3A has been reported to edit nuclear and mitochondrial DNA and to induce the γH2AX (Landry et al., 2011; Suspène et al., 2011a) . Histone H2AX is a variant histone that represents approximately 10% of the total H2A histone proteins in normal human fibroblasts. H2AX is required for checkpoint-mediated cell cycle arrest and DNA repair following double-stranded DNA breaks (Scully and Xie, 2013) . DNA damage, caused by ionizing radiation, UV-light, or radiomimetic agents, results in rapid phosphorylation of H2AX at Ser139 by PI3K-like kinases, including ATM, ATR, and DNA-PK (Redon et al., 2012) . Monoubiquitination of H2AX induced by RING finger protein 2 (RNF2) is also required for the recruitment of active ataxia telangiectasia mutated (ATM) to DNA damage foci and phosphorylation of H2AX at residue Ser139 to generate γH2AX (Wu et al., 2011) . Importantly, a defect in monoubiquitination of H2AX profoundly enhances ionizing radiation sensitivity. Of the seven hA3 proteins, the single cytidine deaminase domain hA3A, hA3C, and hA3H along with double deaminase hA3B have been shown to have a nucleo-cytoplasmic localization (Muckenfuss et al., 2006) . A more recent study, however, demonstrated that hA3A was not genotoxic to cells when expressed in differentiated CD14 þ cells and phorbol 12-myristate 13 acetate treated THP-1 cells (Land et al., 2013) . The discrepancy between these results and that of Landry et al., 2011 could be due to the differences between transfected and endogenous expression. However, in the context of a gene-therapy approach, the possibility that hA3A could induce DNA damage responses following exogenous expression is particularly important. Here, we found that 293 cells expressing hA3A or colA3A led to the induction of γH2AX and its mono-ubiquitinated form, although it was consistently higher with hA3A. As the determinants for the induction of γH2AX are unknown but presumably may be associated with the zinc binding domain, and that colA3A restricted HIV-1 by an apparently novel mechanism, we determined if colA3A 1-100 lost the ability to induce γH2AX expression. Our results indicate that colA3A 1-100 did not induce γH2AX over background levels, indicating that expression of colA3A 1-100 restricted HIV-1 replication without concomitant DNA damage responses. Thus, further elucidation of the amino acid requirements of colA3A 1-100 or mndA3A 1-100 restriction of HIV-1 could result in the use of these truncated proteins in HIV-1 gene therapy approaches.
Materials and methods

Cells and viruses
293 cells were used for transfection of vectors expressing various APOBEC3 proteins, full-length HIV-1 (NL4-3) or HIV-1Δvif. The TZM-bl indicator cell line was used to measure the infectivity of viruses (Derdeyn et al., 2000; Platt et al., 2009; Takeuchi et al., 2008; Wei et al., 2002) . Both cell lines were maintained in Dulbecco's minimal essential medium (DMEM) with 10% fetal bovine serum (R10FBS), 10 mM Hepes buffer, pH 7.3, and 100 U/ml penicillin and 100 μg/ml streptomycin and 5 μg genta- Expression of colA3A in TZM-bl cells TZM-bl cells in 6-well plates ( $50% confluent) were transfected with pcHA-colA3A (the colA3A gene with a HA-tag at the Nterminus subcloned into the KpnI and EcoRV sites of pcDNA3.1( þ) using ExGen500 reagent according to the manufacturers' instructions. At 48 h, the medium was removed and replaced with growth medium containing 1 mg/ml of G-418. The cells were incubated with the medium replaced every 3 days until non-transfected cells were killed. Cells were then trypsinized, resuspended and diluted such that single cells were seeded into each well of 96 well plate. Cells were allowed to grow until they were confluent, trypsinized and seeded into 6 well plates and then into T-25 flasks. Cultures were examined for the expression of HA-colA3A using immunoprecipitation analysis using an antibody against the HA-tag (Santa Cruz Biotechnology). The TZM-bl cells were used for virus infectivity assays.
Assessment of infectivity of Friend murine leukemia virus infectivity in the presence of A3A proteins
One microgram of an infectious molecular clone of F-MuLV, pLRB302, was co-transfected with 500 ng of A3A constructs into 293T cells using the Trans-IT reagent (MirusBio) (Li et al., 2013) . After 2 days, supernatants were collected and titered onto susceptible Mus dunni cells using a focal infectivity assay as previously described (Li et al., 2010) . Cells were also harvested, lysed in RIPA buffer and evaluated for A3A protein expression by loading 15 ug protein into an SDS-PAGE gel and performing a western blot using an anti-HA antibody (Roche). An antibody against beta-actin (clone 8H10D10; Cell Signaling) was used to confirm equal loading.
Assessment of reverse transcription in the presence of HA-colA3A
In order to assess the role of HA-colA3A on reverse transcription, we generated pseudotyped NL4-3 pseudotyped virus with the VSV-G protein. 293 cells in 12 well plates were co-transfected with vector pNL4-3-deltaE-EGFP (2.4 μg), which has the env gene replaced with the gene for GFP, and of vector pVSV-G (0.6 μg), which expresses the VSV G protein using 8 μl of TurboFect Transfection Reagent (Thermo Scientific). At 48 and 96 h, the culture medium was harvested, centrifuged at 1200 Â g for 5 min, and the supernatants pooled and stored at À 86 1C. The infectious viral titers were determined using the TZM-bl cells. The pseudotyped virus was designated as HIV-1ΔE-/VSV-G.
The levels of late reverse transcriptase products were quantified using real time DNA PCR included 293 cells infected and the following oligonucleotide primer set: U5-gag forward; LG564: 5 0 -CCGTCTGTTGTGTGACTCTGGT-3 0 ; U5-gag reverse: LG699: 5 0 -GAGTCCTGCGTCGAGAGATCT-3 0 ; U5-gag probe: LG-FAM: 5 0 -FAM-CCCGAACAGGGACTTGAAAGCGAA-TAMRA-3 0 (Suzuki et al., 2003) . Other controls for the experiment included the use of the reverse transcriptase compound azidothymidine (AZT).
Assessment of integration in the presence of HA-colA3A
To determine if HA-colA3A interfered with viral genome integration, we employed two different assays. The first assay detected the presence of 2-LTR circles, which occurs at a higher frequency when integration is unsuccessful (Butler et al., 2001) . To quantify the levels of 2-LTR circles, 293 cells were transfected with either the empty vector (pcDNA3.1( þ)) or the vector expressing HA-colA3A. At 24 h, equal infectious units of HIV-1ΔE-/VSV-G virus were then used to infect 293 cells for 48 h. Total cellular DNA was purified using DNeasy Blood & Tissue Kit from Qiagen. The 2-LTR circle levels were detected as previously described (Butler et al., 2001) . Real-time PCR was performed using the following oligonucleotide primers:2-LTR circle forward, MH535: 5 0 -AAC-TAGGGAACCCACTGCTTAAG-3 0 ; 2-LTR circle reverse, ES2448 (based on MH536):5 0 -TCCACAGATCAAGGATCTCTTGTC-3 0 ; and 2-LTR probe, MH603:5 0 -(FAM)-ACACTACTTGAAGCACTCAAGGCAAGCTTT-(TAMRA)-3 0 . A standard curve of the amplification being measured was run ranging from 10 to 1 Â 10 11 copies. Reactions containing 1 Â premix (Takara), 0.5 μM forward primer, 0.5 μM reverse primer, 0.25 μM probe and 1 Â RoxDyeII in a 20 μl volume. The thermal cycle is 95 1C for 30 s, followed by 40 cycles of amplification at 5 s at 95 1C and 34 s at 60 1C.
In addition, we assessed the level of integration was by amplification Alu repeat/gag sequences. The oligonucleotides used for detecting Alu-gag products were: (a) Alu-gag forward oligonucleotide primer, MH535 (above); (b) Alu-gag reverse oligonucleotide primer: SB704: 5 0 -TGCTGGGATTACAGGCGTGAG-3 0 . One microlitre of sample from first round regular PCR and subject to real-time PCR with R/U5 primers (forward primer: M667-5 0 GGCTAACTAG-GGAACCCACTGC-3 0 ; reverse primer: AA55 -5 0 CTGCTAGAGATT TTCCACACTGAC-3 0 ) and probe (HIV FAM-5 0 -TAGTGTGTGCCCG-TCTGTTGTGTGAC-3 0 TAM) (Suzuki et al., 2003) . With each experiment, a standard curve of the amplicon being measured was run in duplicate ranging from 10 to 1 Â 10 11 copies plus a no-template control. Reactions contained 1 Â premix (Takara), 0.5 μM forward primer, 0.5 μM reverse primer, 0.25 μM probe primer and 100-500 ng of template DNA and 1 Â RoxDyeII in a 20 μl volume. After initial incubations of 95 1C for 30 s, 40 cycles of amplification were carried out at 5 s at 95 1C, 34 s at 60 1C. Reactions were analyzed using the ABI Prism 7500 sequence detection system (PE-Applied Biosystems, Foster City, California).
Construction of chimeric colobus/human A3A and truncated colA3A proteins
As the hA3A protein and colA3A were phenotypically different regarding restriction of HIV-1 in producer cells, we adopted to a chimeric approach to determine if specific regions of the colA3A protein were responsible for the inhibition of replication. We generated a series of chimeric colobus/human A3A proteins, which included col 1-100 hA3A (N-terminal 100 amino acids of colA3A substituted for same region of hA3A), h 1-100 colA3A, col 1-75 hA3A, col 1-50 hA3A and col 1-33 hA3A. All genes were synthesized with an HA-tag at the N-terminus (Genscript) and subcloned into the pcDNA3.1( þ) vector and sequenced to confirm the integrity of the gene. All lots of A3A plasmids were prepared in Escherichia coli grown at 30 1C and each lot sequenced to insure no mutations were introduced. The expression of each chimeric protein from each plasmid was confirmed by Western blot analysis before viral replication assays were performed.
For construction of truncated colA3A, mndA3A and debA3A proteins, sited-directed mutagenesis was use to introduce stop codons after the N-terminal 100 amino acids (colA3A 1-100 , mndA3A 1-100 , debA3A 1-100 ). All genes were sequenced to insure that only the desired mutations were introduced into the gene.
Immunoprecipitation of viral proteins
For analysis of A3A protein expression in cells, 293 cells in 6well plates were first transfected with either pcDNA3.1( þ) or one expressing each of the A3A proteins and incubated at 37 1C. At 48 h, the medium was removed and the cultures incubated in medium without methionine/cysteine for 2 h and radiolabeled with 300 μCi (per well) of 35 S-methionine/cysteine for 6 h. The medum was removed and the cells lysed in radioimmunoprecipitation assay buffer (RIPA: 50 mM Tris-HCl, pH 7.5; 50 mM NaCl; 0.5% deoxycholate; 0.2% SDS; 10 mM EDTA) and HA-containing proteins immunoprecipitated using a rabbit anti-HA antibody. The immunoprecipitates were collected on Protein A Sepharose beads, washed and boiled in sample reducing buffer. The proteins were separated by SDS-PAGE and proteins visualized by standard autoradiographic techniques.
Immunofluorescence studies of A3A localization
To examine the intracellular localization of HA-colA3A and the truncated HA-colA3A 1-100 proteins, 293 cells on cover slips were transfected with empty vector, or vectors expressing HA-colA3A or HA-colA3A 1-100 . At 48 h post-transfection, cells were washed twice in cold PBS, and fixed in 2% paraformaldehyde for 5 min at room temperature. The cells were washed three times in cold PBS, and incubated in a 0.5% Triton X-100 solution in PBS for 5 min. Cells were once again washed with cold PBS and incubated with a rabbit antibody against the HA-tag conjugated with Alexa488 prepared in PBS with 1% BSA for 1 h. The cells were then washed three times with PBS, mounted and examined using a Leica TCS SPE confocal microscope using a 63 Â objective using filters for Alexa488 and DAPI.
Analysis of virus replication in the presence of A3A proteins
To analyze the virus restriction properties of the different A3A proteins, chimeric colobus/human proteins and truncated A3A proteins described above, 293 cells were first transfected with a vector expressing one of the A3A proteins and with a plasmid containing the complete NL4-3 viral genome. At 48 h post-transfection, the culture medium was collected, clarified by low speed centrifugation and analyzed for virus infectivity using TZM.bl cells. All assays were performed with hA3A (non-restrictive); and colA3A (restrictive). All assays were performed at least four times and analyzed for statistical significance using two-tiered Student's t-test.
